ADORA2A and neoplasm: Myeloid-specific genetic ablation of A2AR has also been shown to promote NK and CD8 T cell responses in multiple tumor models [17], potentially implicating tumor-associated macrophages and myeloid-derived suppressor cells in A2AR-mediated immunosuppression.